BCM
CC icon

Bridgeway Capital Management’s Chemours CC Stock Holding History

Bridgeway Capital Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-67,600
Closed -$2.51M – 1325
2019
Q1 		$2.51M Sell
67,600
-4,900
-7% -$178K 0.03% 450
2018
Q4 		$2.05M Buy
72,500
+2,000
+3% +$63.3K 0.03% 496
2018
Q3 		$2.78M Buy
70,500
+11,500
+19% +$503K 0.03% 526
2018
Q2 		$2.62M Buy
+59,000
New +$2.94M 0.03% 529
2017
Q4 		– Sell
-234,900
Closed -$11.9M – 1391
2017
Q3 		$11.9M Buy
+234,900
New +$11.1M 0.14% 140

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridgeway Capital Management's CC Position: Q2 2019 in Review

Bridgeway Capital Management sold out of Chemours (CC) in Q2 2019, closing a stake of 67,600 shares — an estimated $2.51M sold.

Bridgeway Capital Management first reported a position in CC in Q3 2017 and held it in 5 quarters. The position peaked at $11.9M in Q3 2017. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

  • Bridgeway Capital Management reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
  • Bridgeway Capital Management sold 67,600 Chemours shares in Q2 2019, an estimated $2.51M.
  • Bridgeway Capital Management first reported a position in Chemours in Q3 2017 and held it in 5 quarters.
  • Bridgeway Capital Management's Chemours position peaked at $11.9M in Q3 2017.
  • 488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on Bridgeway Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.